Integra Lifesciences (IART) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

IART Integra Lifesciences

Watchlist

19.280
+0.520+2.77%

Close Nov 1 16:00 ET

20.200
+0.920+4.77%

Pre 07:00 ET

1.50BMarket Cap66.48P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Integra LifeSciences Trims Outlook; Q2 Results Top Estimates; Names Mojdeh Poul As President And CEO
RTTNews06:36 ET
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates
Zacks 06:30 ET
Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Potentially Undervalued?
Yahoo Finance06:08 ET
Integra LifeSciences Holdings Non-GAAP EPS of $0.41 Beats by $0.02, Revenue of $380.83M Beats by $5.04M
Seeking Alpha06:05 ET
Express News | Integra Lifesciences Holdings Outlook 2024 Adj EPS $2.41 to $2.49
Reuters06:05 ET
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Posts Q3 Revenue $380.8M
MT Newswires06:04 ET

Comments

Money Mover

Jul 1 10:35

Going to miss guidance/earnings

$Integra Lifesciences (IART.US)$ its a buy at $24

Money Mover

Jun 27 14:20

$Integra Lifesciences (IART.US)$ Integra LifeSciences Price Target Cut to $25.00/Share From $45.00 by Wells Fargo

Moomoo AI

Feb 11 08:35

EPS growth doesn't align with share price, indicating it may not reflect business performance or growth expectations may have been high. Integra LifeSciences Holdings' performance led to a 3% annual loss for shareholders over five years. Investors should note 3 warning signs.

While Shareholders of Integra LifeSciences Holdings (NASDAQ:IART) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown

Moomoo AI

Jan 29 04:30

Insider transactions suggest a positive outlook for Integra LifeSciences Holdings, with insiders net buying the stock. The level of insider ownership indicates a reasonable degree of alignment with shareholder interests.

Several Insiders Invested In Integra LifeSciences Holdings Flagging Positive News

Moomoo AI

Jan 15 05:36

Integra LifeSciences Holdings trades at a low price, suggesting a buying opportunity. Higher cash flow is expected, potentially boosting share valuation. The positive outlook seems not fully factored into the share price, indicating it's not too late to buy IART.